CONSTELLATION PHARMACEUTICALS CEO Jigar Raythatha's 2019 pay falls 51% to $2.3M
CONSTELLATION PHARMACEUTICALS reports 2019 executive compensation
By ExecPay News
Published: April 24, 2020
CONSTELLATION PHARMACEUTICALS reported fiscal year 2019 executive compensation information on April 24, 2020.
In 2019, three executives at CONSTELLATION PHARMACEUTICALS received on average a compensation package of $1.5M, a 37% decrease compared to previous year.
Average pay of disclosed executives at CONSTELLATION PHARMACEUTICALS
Jigar Raythatha, Chief Executive Officer, received $2.3M in total, which decreased by 51% compared to 2018. 66% of Raythatha's compensation, or $1.5M, was in option awards. Raythatha also received $290K in bonus, $484K in salary, as well as $7.6K in other compensation.
Adrian Senderowicz, Chief Medical Officer, received a compensation package of $1.2M, which increased by 5% compared to previous year. 49% of the compensation package, or $579K, was in option awards.
Emma Reeve, Chief Financial Officer, earned $1.1M in 2019, a 24% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2020.